SKLKY yields 0.81% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, SKLKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKLKY + JNJ for your $10,000?
Shinsei Bank, Limited provides various banking and financial products and services to individual customers, corporations, public-sector entities, and financial institutions in Japan. It offers Yen/foreign currency deposits, and structured deposits; home mortgages; corporate loans, finance for start-up, real estate non-recourse finance, project finance, renewable energy finance, acquisition finance, ship finance, healthcare finance, sustainable finance/impact finance, M&A related finance, and specialty finance; and loan syndication. The company also provides foreign exchange and derivatives, M&A advisory, credit trading, private equity, business succession and change/closure support services, and wealth management, as well as prepaid and credit cards. In addition, it engages in the provision of trust services, leasing related financial products and services, equity related and other capital markets transactions, securities, asset and wealth management, unsecured loans, housing loans, investment trusts, brokerage, life and non-life insurance, consumer finance products and services, credit guarantee services, installment sales finance, credit cards, loan and payment services, and treasury services. The company was formerly known as The Long-Term Credit Bank of Japan, Limited and changed its name to Shinsei Bank, Limited in June 2000. Shinsei Bank, Limited was incorporated in 1952 and is headquartered in Tokyo, Japan.
Full SKLKY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.